UNICREDIT BANK/CALL/INTUITIVE SURGICAL/250/0.1/19.06.24 Stock

Warrant

DE000HC3L647

Market Closed - BOERSE MUENCHEN 15:41:10 2024-05-31 EDT
13.79 EUR -2.41% Intraday chart for UNICREDIT BANK/CALL/INTUITIVE SURGICAL/250/0.1/19.06.24
1 month+18.98%
3 months+4.87%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 13.79 -2.41%
24-05-30 14.13 +2.47%
24-05-29 13.79 -0.79%
24-05-28 13.9 -4.01%
24-05-27 14.48 +0.49%

Real-time BOERSE MUENCHEN

Last update May 31, 2024 at 03:41 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying INTUITIVE SURGICAL, INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC3L64
ISINDE000HC3L647
Date issued 2023-01-27
Strike 250 $
Maturity 2024-06-19 (17 Days)
Parity 10 : 1
Emission price 4.89
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 14.65
Lowest since issue 3.06
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 1.608
Difference Strike -152.1 $
Difference Strike %-60.85%
Intrinsic value 14.02

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
402.1 USD
Average target price
423.6 USD
Spread / Average Target
+5.33%
Consensus